Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still’s disease
Author:
Affiliation:
1. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
Funder
The authors have no funding to report
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1942832
Reference75 articles.
1. Mechanisms, biomarkers and targets for adult-onset Still’s disease
2. Still's disease in the adult.
3. Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart
4. Adult-onset Still's disease—pathogenesis, clinical manifestations, and new treatment options
5. Adult-onset Still's disease
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The latest advances in the use of biological DMARDs to treat Still’s disease;Expert Opinion on Biological Therapy;2024-02
2. Recent advances and evolving concepts in Still’s disease;Nature Reviews Rheumatology;2024-01-11
3. Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims database;International Journal of Rheumatic Diseases;2023-08-06
4. Bibliometrics analysis on the research status and trends of adult-onset Still’s disease: 1921-2021;Frontiers in Immunology;2022-07-18
5. Was ist gesichert in der Therapie von autoinflammatorischen Fiebererkrankungen?;Der Internist;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3